Regional Analysis
Preterm Birth and PROM Testing Market Regional Insights
- North America is expected to be the largest market for preterm birth and PROM testing during the forecast period, accounting for over 40.2% of the market share in 2023. The growth of the market in North America is attributed to the high prevalence of preterm births, presence of major players, and increasing adoption of innovative prenatal screening tests in the region. For instance, according to Centers for Disease Control and Prevention, in the U.S., around one in 10 newborns were affected by preterm birth in 2022. Preterm birth rates in the U.S. in 2022 were almost 50% higher among African-American women (14.6%) than among White or Hispanic women (9.4% and 10.1%, respectively).
- Europe is expected to be the second-largest market for preterm birth and PROM testing, accounting for over 32.3% of the market share in 2023. The growth of the market in Europe is attributed to the rising awareness about prenatal testing, government funding for prenatal screening programs, and advancing healthcare infrastructure in the region.
- Asia Pacific market is expected to be the fastest-growing market for preterm birth and PROM testing, and it is projected to grow at a CAGR of over 15.1% during the forecast period. The growth of the market in Asia Pacific is attributed to the large target population, improving healthcare expenditure, and growing investments by leading companies in the region.
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
U.S.: 
U.K. : 
India : 
